Merit Medical Systems, Inc. · NASDAQ:MMSI
Merit Medical Systems — Merger or Acquisition (November 2017)
9 slides from Merit Medical Systems's merger presentation, Nov 16, 2017
Slide 1: Disclosure Regarding Forward-Looking Statements
Disclosure Regarding Forward-Looking Statements This presentation and any accompanying management commentary include “forward-looking statements,” as defined within applicable securities laws and regulations. All statements in this presentation, other than statements of historical fact, are “forward
Slide 2: Deal Highlights Biopsy
Deal Highlights Biopsy Merit proposes to acquire the following assets: Achieve™ Biopsy Devices Temno™ Biopsy Devices Tru-Cut™ Biopsy Device Tru-Cut™
Slide 3: Deal Highlights Biopsy
Deal Highlights Biopsy Complementary to Merit’s product offering and strategically fits into its current biopsy portfolio Merit CorVocet™ Biopsy Devices Merit Bone Biopsy Devices
Slide 4: Deal Highlights Home Drainage
Deal Highlights Home Drainage Merit proposes to acquire the following assets: Aspira® Pleural Effusion Drainage System Aspira® Peritoneal Drainage System Complementary to Merit’s product offering and strategically fits into its current drainage portfolio
Slide 5: Projected Financial Highlights
Anticipated annual revenues of $42-$48 million Anticipated adjusted gross margins of 60-70% on acquired products Anticipated combined non-GAAP gross margin accretion of 50-120 basis points Anticipated non-GAAP EPS of $0.10-$0.19 and GAAP EPS of $0.01-$0.08 in adjusted accretion FY18 Purchase price o
Slide 6: Strategic Fit Within Merit's PI Business Line
Strategic Fit Within Merit’s PI Business Line
Slide 7: Global Capability – Global Expansion, Wholesale to Retail
Global Capability – Global Expansion, Wholesale to Retail
Slide 8: Global Capability - Global Expansion
ZA Global Capability - Global Expansion, V Maosticht, Moscow, Rusio = Venlo, ‘The Netherlands Balog Che Nethedonds
Slide 9: Slide 9
Merit Medical Systems — Merger or Acquisition (November 2017) on 6ix